The Boston Home to Honor Biogen Idec CEO George Scangos at Gala

The Boston Home to Honor Biogen Idec CEO George Scangos at Gala

The Boston Home's 2012 Innovation & Inspiration Galawill take placeon Thursday, November 15 at 6:00 p.m. at the Artists for Humanity EpiCenter in South Boston. Senator John Kerry is the Honorary Chair and Maureen Feeney and Bill Walczak are the Gala co-chairs. Tickets are $250 and available at

At the Gala, Biogen Idec's CEO George A. Scangos, Ph.D. will be presented with The Boston Home's Excellence in Care Award for his leadership role in the biotech industry and his commitment to people living with multiple sclerosis.

"Throughout his career, George Scangos has embodied both innovation and care," said Marva Serotkin, President and CEO of The Boston Home. "His leadership at Biogen Idec is making a difference in improving the quality of care for people living with multiple sclerosis."

The Boston Home is a nationally recognized residence and center for care of adults with advanced progressive neurological diseases, primarily multiple sclerosis. With its newly launched Wheelchair Enhancement Center, The Boston Home is at the forefront of using technology to promote independence and improve quality of life for individuals with severe disabilities.

Lynn native George A. Scangos, Ph.D. was appointed CEO and a member of the Board of Directors of Biogen Idec in June 2010. Previously he was President and CEO and a director of Exelixis, Inc., President of Bayer Biotechnology and a Professor of Biology at Johns Hopkins University, where he remains an Adjunct Professor. Dr. Scangos holds a B.A. in Biology from Cornell University, a Ph.D. in Microbiology from the University of Massachusetts, and was a Jane Coffin Childs Post-Doctoral Fellow at Yale University.

Since 1881, The Boston Home has provided specialized clinical care and residential services for adults with progressive neurological diseases, primarily advanced MS. The Boston Home has extended its mission to serve individuals living with progressive neurological diseases in the community with services including B.Fit!, a day wellness and socialization program, The Wheelchair Enhancement Center, an Outpatient Seating Clinic, and rehab services. Through its Institute, the Boston Home educates healthcare professionals and researchers. The Boston Home is 2012 technology Innovator of the Year.For more information, visit

Suggested Articles

Disarm Therapeutics signed on Alvin Shih, M.D., the former Retrophin R&D chief who went on to helm Enzyvant, as its full-time CEO.

Pact Pharma launched a phase 1 trial of a technology designed to attack solid tumors with CAR-T cells tailored to individual patients.

Intec's candidate uses a drug delivery system designed to improve on Merck’s Sinemet but was unable to beat the product in a late-phase test.